152 related articles for article (PubMed ID: 35316518)
21. Diagnostic Accuracy of T1-Weighted Dynamic Contrast-Enhanced-MRI and DWI-ADC for Differentiation of Glioblastoma and Primary CNS Lymphoma.
Lin X; Lee M; Buck O; Woo KM; Zhang Z; Hatzoglou V; Omuro A; Arevalo-Perez J; Thomas AA; Huse J; Peck K; Holodny AI; Young RJ
AJNR Am J Neuroradiol; 2017 Mar; 38(3):485-491. PubMed ID: 27932505
[TBL] [Abstract][Full Text] [Related]
22. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.
Calli C; Kitis O; Yunten N; Yurtseven T; Islekel S; Akalin T
Eur J Radiol; 2006 Jun; 58(3):394-403. PubMed ID: 16527438
[TBL] [Abstract][Full Text] [Related]
23. Differentiation between glioblastomas and brain metastases and regarding their primary site of malignancy using dynamic susceptibility contrast MRI at 3T.
Askaner K; Rydelius A; Engelholm S; Knutsson L; Lätt J; Abul-Kasim K; Sundgren PC
J Neuroradiol; 2019 Nov; 46(6):367-372. PubMed ID: 30389510
[TBL] [Abstract][Full Text] [Related]
24. Accuracy of apparent diffusion coefficients and enhancement ratios on magnetic resonance imaging in differentiating primary cerebral lymphomas from glioblastoma.
Anwar SSM; Baig MZ; Laghari AA; Mubarak F; Shamim MS; Jilani UA; Khalid MU
Neuroradiol J; 2019 Oct; 32(5):328-334. PubMed ID: 31188064
[TBL] [Abstract][Full Text] [Related]
25. Differentiating brain metastasis from glioblastoma by time-dependent diffusion MRI.
Kamimura K; Kamimura Y; Nakano T; Hasegawa T; Nakajo M; Yamada C; Akune K; Ejima F; Ayukawa T; Ito S; Nagano H; Takumi K; Nakajo M; Uchida H; Tabata K; Iwanaga T; Imai H; Feiweier T; Yoshiura T
Cancer Imaging; 2023 Aug; 23(1):75. PubMed ID: 37553578
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of the apparent diffusion coefficient for the evaluation of the white matter to differentiate between glioblastoma and brain metastases.
Miquelini LA; Pérez Akly MS; Funes JA; Besada CH
Radiologia; 2016; 58(3):207-13. PubMed ID: 26655126
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic value of apparent diffusion coefficient in differentiating between high-grade gliomas and brain metastases.
Caravan I; Ciortea CA; Contis A; Lebovici A
Acta Radiol; 2018 May; 59(5):599-605. PubMed ID: 28835111
[TBL] [Abstract][Full Text] [Related]
28. [Value of Minimum Apparent Diffusion Coefficient in Peritumoral Edema in the Differential Diagnosis between Primary Central Nervous System Lymphoma and Glioblastoma].
Li MG; Chen ZY; Liu G; Xiao HF; Chen XJ; Lou X; Ma L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Apr; 40(2):146-150. PubMed ID: 29724302
[TBL] [Abstract][Full Text] [Related]
29. Multimodal MR Features of 8 Cases of Epithelioid Glioblastoma.
Zhao JP; Cui CX; Wang JC; Su HW; Duan CF; Liu XJ
Biomed Res Int; 2020; 2020():9586806. PubMed ID: 33123592
[TBL] [Abstract][Full Text] [Related]
30. Differentiation of recurrent brain tumor versus radiation injury using diffusion tensor imaging in patients with new contrast-enhancing lesions.
Sundgren PC; Fan X; Weybright P; Welsh RC; Carlos RC; Petrou M; McKeever PE; Chenevert TL
Magn Reson Imaging; 2006 Nov; 24(9):1131-42. PubMed ID: 17071335
[TBL] [Abstract][Full Text] [Related]
31. Multiparametric MR Imaging of Diffusion and Perfusion in Contrast-enhancing and Nonenhancing Components in Patients with Glioblastoma.
Boonzaier NR; Larkin TJ; Matys T; van der Hoorn A; Yan JL; Price SJ
Radiology; 2017 Jul; 284(1):180-190. PubMed ID: 28240563
[TBL] [Abstract][Full Text] [Related]
32. Spectroscopic, diffusion and perfusion magnetic resonance imaging at 3.0 Tesla in the delineation of glioblastomas: preliminary results.
Di Costanzo A; Trojsi F; Giannatempo GM; Vuolo L; Popolizio T; Catapano D; Bonavita S; d'Angelo VA; Tedeschi G; Scarabino T
J Exp Clin Cancer Res; 2006 Sep; 25(3):383-90. PubMed ID: 17167979
[TBL] [Abstract][Full Text] [Related]
33. DTI and PWI analysis of peri-enhancing tumoral brain tissue in patients treated for glioblastoma.
Stecco A; Pisani C; Quarta R; Brambilla M; Masini L; Beldì D; Zizzari S; Fossaceca R; Krengli M; Carriero A
J Neurooncol; 2011 Apr; 102(2):261-71. PubMed ID: 20658351
[TBL] [Abstract][Full Text] [Related]
34. Validation of combined use of DWI and percentage signal recovery-optimized protocol of DSC-MRI in differentiation of high-grade glioma, metastasis, and lymphoma.
Cindil E; Sendur HN; Cerit MN; Dag N; Erdogan N; Celebi FE; Oner Y; Tali T
Neuroradiology; 2021 Mar; 63(3):331-342. PubMed ID: 32821962
[TBL] [Abstract][Full Text] [Related]
35. Differentiation between vasogenic-edema versus tumor-infiltrative area in patients with glioblastoma during bevacizumab therapy: a longitudinal MRI study.
Artzi M; Bokstein F; Blumenthal DT; Aizenstein O; Liberman G; Corn BW; Ben Bashat D
Eur J Radiol; 2014 Jul; 83(7):1250-1256. PubMed ID: 24809637
[TBL] [Abstract][Full Text] [Related]
36. Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.
Kolakshyapati M; Adhikari RB; Karlowee V; Takayasu T; Nosaka R; Amatya VJ; Takeshima Y; Akiyama Y; Sugiyama K; Kurisu K; Yamasaki F
J Neurosurg; 2018 Mar; 128(3):667-678. PubMed ID: 28362236
[TBL] [Abstract][Full Text] [Related]
37. Spatial discrimination of glioblastoma and treatment effect with histologically-validated perfusion and diffusion magnetic resonance imaging metrics.
Prah MA; Al-Gizawiy MM; Mueller WM; Cochran EJ; Hoffmann RG; Connelly JM; Schmainda KM
J Neurooncol; 2018 Jan; 136(1):13-21. PubMed ID: 28900832
[TBL] [Abstract][Full Text] [Related]
38. Utility of Percentage Signal Recovery and Baseline Signal in DSC-MRI Optimized for Relative CBV Measurement for Differentiating Glioblastoma, Lymphoma, Metastasis, and Meningioma.
Lee MD; Baird GL; Bell LC; Quarles CC; Boxerman JL
AJNR Am J Neuroradiol; 2019 Sep; 40(9):1445-1450. PubMed ID: 31371360
[TBL] [Abstract][Full Text] [Related]
39. Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging.
Kickingereder P; Wiestler B; Sahm F; Heiland S; Roethke M; Schlemmer HP; Wick W; Bendszus M; Radbruch A
Radiology; 2014 Sep; 272(3):843-50. PubMed ID: 24814181
[TBL] [Abstract][Full Text] [Related]
40. Susceptibility-weighted imaging provides complementary value to diffusion-weighted imaging in the differentiation between pyogenic brain abscesses, necrotic glioblastomas, and necrotic metastatic brain tumors.
Lai PH; Chung HW; Chang HC; Fu JH; Wang PC; Hsu SH; Hsu SS; Lin HS; Chuang TC
Eur J Radiol; 2019 Aug; 117():56-61. PubMed ID: 31307653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]